Biogen (Switzerland)
In research, Biogen (Switzerland) stands highest in Life Sciences (#4,449 of 14,347 worldwide), Medicine (#8,234 of 17,978 worldwide) and Health Sciences (#10,963 of 20,462 worldwide), over all time.
- World rank, all time
- #9,995 of 42,892
- Rank in Switzerland
- #91 of 429
- Research works
- 376 ▼ 32% vs 2013–17
- Citations
- 14k 37.2 per fractional work
- Top-10% rate
- 14.4% record average 16.5%
- Open access
- 56% world 28%
What is Biogen (Switzerland) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #4,449 of 14,347 | 21.0% | 178 | |
| MedicineField | #8,234 of 17,978 | 24.8% | 128 | |
| Health SciencesDomain | #10,963 of 20,462 | 24.4% | 134 |
Each strip is that field’s whole ranked pool, with the notch where Biogen (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.1×. Every wedge is a field page.
- Immunology and Microbiology 10.1×
- Economics, Econometrics and Finance 4.9×
- Agricultural and Biological Sciences 2.7×
- Medicine 2.2×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Mathematics 1.3×
- Health Professions 1.2×
- Decision Sciences 1.1×
- Chemistry 1.0×
- Chemical Engineering 0.8×
- Neuroscience 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Environmental Science 0.4×
- Nursing 0.3×
- Social Sciences 0.3×
- Business, Management and Accounting 0.3×
- Psychology 0.1×
- Materials Science 0.1×
- Engineering 0.1×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Biogen (Switzerland)?
Ranked on the composite score, Mark A. Payton and Ioannis Grigoriadis lead among researchers whose main affiliation is Biogen (Switzerland).
- 1 Mark A. Payton Switzerland · #919,403 worldwide 72 citations · 15 works
- 2 Ioannis Grigoriadis Switzerland · #1,602,846 worldwide 0 citations · 23 works
Which keywords describe research at Biogen (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Biopharmaceuticals, Immunogenicity, Bioanalytical Methods, Biosimilars, Autoantibodies, Diagnostic Criteria and Cost-effectiveness Analysis.
- Microsurgical Reconstruction
- Fc Receptors
- Antibody Engineering
- Neurodegeneration
- Epidemiology
- Immunosuppression
- Therapeutic Antibodies
- Multiple Sclerosis
- Health Utility Measures
- Quality of Life
- Biosimilars
- Autoantibodies
- Biopharmaceuticals
- Monoclonal Antibodies
- Immunogenicity
- Bioanalytical Methods
- Diagnostic Criteria
- Cost-effectiveness Analysis
- Cognitive Impairment
- Neuromyelitis Optica
- Glycosylation
- Antiphospholipid Syndrome
- Genetics
- Systemic Lupus Erythematosus
- Complications
- Free Flap
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Monoclonal Antibodies4▲ 112×3 topics
- Biopharmaceuticals3▲ 142×2 topics
- Immunogenicity3▲ 170×2 topics
- Autoantibodies2▲ 25×7 topics
- Bioanalytical Methods2▲ 298×1 topic
- Biosimilars2▲ 298×1 topic
- Diagnostic Criteria2▲ 26×4 topics
- Quality of Life2▲ 3.9×5 topics
- Cost-effectiveness Analysis2▲ 61×1 topic
- Health Utility Measures2▲ 61×1 topic
- Cognitive Impairment2▲ 20×3 topics
- Multiple Sclerosis2▲ 125×1 topic
- Neuromyelitis Optica2▲ 125×1 topic
- Therapeutic Antibodies2▲ 59×2 topics
- Glycosylation2▲ 35×2 topics
- Immunosuppression1▲ 40×2 topics
- Antiphospholipid Syndrome1▲ 67×1 topic
- Epidemiology1▼ 0.75×17 topics
- Genetics1▲ 4.5×4 topics
- Neurodegeneration1▲ 10×4 topics
- Systemic Lupus Erythematosus1▲ 60×1 topic
- Antibody Engineering1▲ 50×1 topic
- Complications1▲ 5.7×3 topics
- Fc Receptors1▲ 50×1 topic
- Free Flap1▲ 64×1 topic
- Microsurgical Reconstruction1▲ 64×1 topic
Which research topics does Biogen (Switzerland) publish most on?
By volume in 2022–2025: Biosimilars and Bioanalytical Methods, Health Systems, Economic Evaluations, Quality of Life, Multiple Sclerosis Research Studies and Systemic Lupus Erythematosus Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biosimilars and Bioanalytical Methods Immunology 2 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 3 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 4 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 6 Reconstructive Surgery and Microvascular Techniques Surgery 1 works
- 7 Polyomavirus and related diseases Oncology 1 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 9 Rabbits: Nutrition, Reproduction, Health Animal Science and Zoology 1 works
- 10 Food and Agricultural Sciences Food Science 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biogen (Switzerland)'s research output changed?
Output in 2018–2022 was 32% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zug
- Varian Medical Systems (Switzerland)
- University of Teacher Education Zug
- Amgen (Switzerland)
- AstraZeneca (Switzerland)
- RHI Magnesita (Switzerland)
- Johnson & Johnson (Switzerland)
- SHL Medical (Switzerland)
- Sucampo (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.